Abiopharma

ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference

Protara Therapeutics to Participate in Upcoming Investor Conferences

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™

CareCloud Named “Top Healthcare IT Pick for 2025” by Maxim Group; AI Initiative Recognized as Key Growth Driver

Mallinckrodt and Endo Announce Significant Progress in Proposed Merger

iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients

Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update

MediWound